E-ISSN 2602-3164
ejmi. 2018; 2(2): 101-103 | DOI: 10.14744/ejmi.2018.76376

Metastatic Renal Cell Carcinoma: A Case Report of Multiple Treatment Options and a Review of the Literature

Mahmut Buyuksimsek1, Ismail Oguz Kara1, Abdullah Evren Yetisir1, Cem Mirili1, Serkan Gokcay1, Ali Ogul1, Mert Tohumcuoglu1, Hilmi Erdem Sumbul2, Kubra Buyuksimsek3
1Department of Oncology, Cukurova University Faculty of Medicine, Adana, Turkey, 2Department of Internal Medicine, Health Science Universty, Adana City Training and Research Hospital, Adana, Turkey, 3Department of Children Emergency, Seyhan State Hospital, Adana, Turkey

Renal cell carcinoma (RCC), the most common type of kidney cancer, may present in many different clinical forms. The treatment order to be given in cases of RCC, for which there are several alternative therapies, has become an important issue. A patient diagnosed with RCC in 2009 was treated with interferon, sorafenib, everolimus, nivolumab, and axitinib for 7 years. This patient was followed up for 4 years after the detection of hepatic metastasis; this patient was the first at this center to receive cytokine treatment, tyrosine kinase inhibitor, and immunotherapy with axitinib, consecutively.


Cite This Article

Buyuksimsek M, Kara I, Yetisir A, Mirili C, Gokcay S, Ogul A, Tohumcuoglu M, Sumbul H, Buyuksimsek K. Metastatic Renal Cell Carcinoma: A Case Report of Multiple Treatment Options and a Review of the Literature. ejmi. 2018; 2(2): 101-103

Corresponding Author: Buyuksimsek M.

Full Text PDF